
Publications
Fragment-based development of small molecule inhibitors targetingMycobacterium tuberculosischolesterol metabolism
(2024)
(doi: 10.1101/2024.10.28.620643)
A Fragment‐Based Competitive 19F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling
Angewandte Chemie
(2024)
136
e202406846
(doi: 10.1002/ange.202406846)
A Fragment-Based Competitive 19F LB-NMR Platform For Hotspot-Directed Ligand Profiling.
Angewandte Chemie International Edition
(2024)
63
e202406846
(doi: 10.1002/anie.202406846)
Fragment-Merging Strategies with Known Pyrimidine Scaffolds Targeting Dihydrofolate Reductase from Mycobacterium tuberculosis
Chemmedchem
(2023)
18
e202300240
(doi: 10.1002/cmdc.202300240)
Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**
Angewandte Chemie (Weinheim an der Bergstrasse, Germany)
(2023)
135
e202300221
(doi: 10.1002/ange.202300221)
Structure Based Discovery of Inhibitors of CYP125 and CYP142 from Mycobacterium tuberculosis.
Chemistry
(2023)
29
e202203868
(doi: 10.1002/chem.202203868)
Pantothenate biosynthesis in Toxoplasma gondii tachyzoites is not a drug target.
International Journal for Parasitology: Drugs and Drug Resistance
(2023)
22
1
(doi: 10.1016/j.ijpddr.2023.03.003)
Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference**
Angewandte Chemie (International ed. in English)
(2023)
62
e202300221
(doi: 10.1002/anie.202300221)
Microfluidic preparation of composite hydrogel microparticles for the staining of microalgal cells*
Colloids and Surfaces B Biointerfaces
(2022)
221
113026
- Page 1